PIIND2024-04-012024-06-30 PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses03Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses04Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses05Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses06Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses07Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses08Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses09Member PIIND2024-04-012024-06-30in-bse-fin:OneOperatingExpenses10Member PIIND2024-06-30 PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue01Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue02Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults01Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults02Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets01Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets02Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PIIND2024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member PIIND2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PIIND2024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member PIIND2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2024-04-012024-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2024-04-012024-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 523642 PIIND NOTLISTED PI Industries Limited Equity 2024-04-01 2025-03-31 2024-08-06 2024-07-25 INR Millions First quarter 14:00:00 18:20:00 2024-08-06 2024-08-06 Not applicable Multi segment 2024-04-01 2024-06-30 Unaudited Consolidated 20689000000.00 727000000.00 21416000000.00 8483000000.00 282000000.00 1212000000.00 2001000000.00 83000000.00 834000000.00 2879000000.00 15774000000.00 5642000000.00 0.00 5642000000.00 1010000000.00 165000000.00 1175000000.00 0.00 4467000000.00 0.00 0.00 0.00 21000000.00 4488000000.00 56000000.00 4544000000.00 4544000000.00 0.00 4544000000.00 0.00 152000000.00 1 29.59 29.59 0.00 0.00 29.59 29.59 Notes: 1.The above Consolidated financial results were reviewed and recommended by the Audit Committee of the Company and approved by the Board of Directors at their meeting held on August 06, 2024. 2. Consolidated Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The Consolidated financial results include the results of the following entities namely, Parent Company - Pl Industries Limited; Subsidiaries (including step down subsidiaries): (a) PILL Finance and Investments Limited (b) Pl Life Science Research Limited (c) Pl Flowtech B.V. (d) Pl Japan Co. Limited (e) Jivagro Limited (f) Pl Bioferma Private limited (g) Pl Fermachem Private Limited (h) Pl Health Sciences Limited (i) Pl Health Sciences USA, LLC (j) Pl Health Sciences Netherlands BV (k) Archimica S.p.A Italy (I) Pl Industries Management Consultancies L.L.C Dubai; Controlled trust - Pl ESOP Trust; Joint Venture - Pl Kumlai Private Limited; Associate - Solinnos Agro Sciences Private Limited. 4. The Figures for the March quarter are the balancing figures between audited figures in respect of full financial year and the published unaudited year to date figures up to the third quarter of respective financial year. 5. The Company raised Rs. 20,000 Mn during the quarter ended September 30, 2020 through Qualified lnstltutlonal Placement (QIP) of equity shares. Out of the funds received of Rs.19,750 Mn (net of expense of Rs. 250 Mn), the Company invested Rs. 9,840 Mn In its subsidiary, Pl Health Sciences Limited. Balance funds of Rs. 9,910 Mn received pursuant to QIP remain Invested in fixed deposits, liquid and other debt mutual funds. 6. During the quarter, the Company ( Pl Industries Ltd. ) has made an offer for acquisition of entire share capital of Plant Health Care Pie, a England and Wales incorporated Company. This acquisition will be made through its newly incorporated wholly owned subsidiary, Pl Industries Management Consultancies L.L.C. , Dubai and is subject to a court sanctioned scheme of arrangement under the applicable law, which is expected to be completed by Q2 FY25.There is no impact of the above acquisition In the current period results. 7 Segment information as per Ind AS 108 Operating Segments is as per annexure I. Advertisement & Sales Promotion 146000000.00 Environment & Pollution Control Expenses 381000000.00 Freight & Cartage 127000000.00 Laboratory & Testing Charges 128000000.00 Legal & professional fees 382000000.00 Net Impairment losses on Financial Assets 39000000.00 Others 554000000.00 Power, Fuel & Water 615000000.00 Repairs & Maintenance 282000000.00 Travelling and Conveyance 225000000.00 Agro Chemicals 20439000000.00 Pharma 253000000.00 20692000000.00 3000000.00 20689000000.00 Agro Chemicals 6379200000.00 Pharma -716600000.00 5662600000.00 0.00 0.00 5662600000.00 Agro Chemicals 101165000000.00 Pharma 12679000000.00 113844000000.00 Agro Chemicals 83418000000.00 Pharma 8437000000.00 91855000000.00 0.00 91855000000.00 Remeasurements gain/(loss) on cash flow hedges -23000000.00 -23000000.00 -8000000.00 Effective portion of gain/(loss) on cashflow hedges 130000000.00 Exchange difference on translation of foreign operations -37000000.00 93000000.00 22000000.00